BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15962502)

  • 1. [Transitional cell carcinoma of the upper urinary tract new concepts in management].
    Rouprêt M; Cussenot O
    Presse Med; 2005 Apr; 34(8):601-7. PubMed ID: 15962502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
    Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O
    Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite instability in urothelial carcinoma of the upper urinary tract.
    Amira N; Rivet J; Soliman H; Cancel-Tassin G; Le Duc A; Janin A; Cussenot O
    J Urol; 2003 Oct; 170(4 Pt 1):1151-4. PubMed ID: 14501713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].
    Olagui GS; Pignot G; Rouquette A; Vieillefond A; Amsellem-Ouazana D; de Longchamps NB; Radenen B; Zerbib M; Terris B
    Bull Cancer; 2014 Feb; 101(2):144-50. PubMed ID: 24556207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA repair gene polymorphisms may be associated with prognosis of upper urinary tract transitional cell carcinoma.
    Sasaki M; Sakano S; Okayama N; Akao J; Hara T; Kawai Y; Ohmi C; Hinoda Y; Naito K
    Neoplasia; 2008 Mar; 10(3):255-65. PubMed ID: 18320070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
    Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications.
    Lynch HT; Taylor RJ; Lynch JF; Knezetic JA; Barrows A; Fodde R; Wijnen J; Wagner A
    Am J Gastroenterol; 2003 Mar; 98(3):664-70. PubMed ID: 12650804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M;
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma.
    Bai S; Nunez AL; Wei S; Ziober A; Yao Y; Tomaszewski JE; Bing Z
    Am J Clin Pathol; 2013 Jun; 139(6):765-70. PubMed ID: 23690119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
    Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
    Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Mongiat-Artus P
    Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
    [No Abstract]   [Full Text] [Related]  

  • 18. Is nephroureterectomy necessary in all cases of upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney.
    Elliott DS; Segura JW; Lightner D; Patterson DE; Blute ML
    Urology; 2001 Aug; 58(2):174-8. PubMed ID: 11489692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 123 cases of transitional cell carcinoma (TCC) of upper urinary tract].
    Liang YY; Dai YP; Huang ZY; Zheng KL; Mei H
    Ai Zheng; 2005 Jan; 24(1):91-4. PubMed ID: 15642209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
    Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
    Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.